Patents by Inventor Mohammad Athar

Mohammad Athar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250304680
    Abstract: Provided herein are methods for treating or preventing inflammatory skin disorders, such as Hidradenitis suppurativa, by administering to a subject having or at risk of developing the inflammatory skin disorder an agent that inhibits NK cell activity.
    Type: Application
    Filed: May 16, 2023
    Publication date: October 2, 2025
    Applicant: THE UAB RESEARCH FOUNDATION
    Inventors: Chander Raman, Mohammad Athar, Bharat Kumar Mishra, Mahendra P. Kashyap, Shahid M. Mukhtar
  • Patent number: 12215108
    Abstract: The present disclosure is concerned with purine diamine compounds for the treatment of conditions associated with BRD4, RIP3K, and/or IL6 signaling dysfunction such as, for example, cancer (e.g., lung cancer, skin cancer, bladder cancer, kidney cancer, liver cancer), arsenicosis, arsenic poisoning, inflammation, skin lesions, dysfunction of systemic organs, and skin blisters. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: February 4, 2025
    Assignees: Southern Research Institute, UAB Research Foundation, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Mark J. Suto, Bini Mathew, Corinne E. Augelli-Szafran, Marina Fosso Yatchang, Mohammad Athar, Anupam Agarwal, Ritesh Kumar Srivastava, Suhail Muzaffar, Jasim Khan
  • Publication number: 20230219958
    Abstract: The present disclosure is concerned with purine diamine compounds for the treatment of conditions associated with BRD4, RIP3K, and/or IL6 signaling dysfunction such as, for example, cancer (e.g., lung cancer, skin cancer, bladder cancer, kidney cancer, liver cancer), arsenicosis, arsenic poisoning, inflammation, skin lesions, dysfunction of systemic organs, and skin blisters. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: January 10, 2023
    Publication date: July 13, 2023
    Inventors: Mark J. Suto, Bini Mathew, Corinne E. Augelli-Szafran, Marina Fosso Yatchang, Mohammad Athar, Anupam Agarwal, Ritesh Kumar Srivastava, Suhail Muzaffar, Jasim Khan
  • Patent number: 11526375
    Abstract: Aspects of the disclosure relate to a machine-learning transaction-prediction engine for seasoning an anticipated manual transaction. The transaction may occur in a transaction session. The seasoning may occur prior to execution of the anticipated manual transaction. The transaction-prediction engine may include a receiving/storage module configured to receive and store identification information of the transactor. The engine may also include a step-retrieval module configured to retrieve a set of in-session transaction steps associated with the transactor. In addition, the engine may include a history-retrieval module configured to retrieve, based on the stored identification information, historical transactional information associated with the transactor. The historical transaction information comprising a plurality of historical transaction patterns associated with the transactor.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: December 13, 2022
    Assignee: Bank of America Corporation
    Inventors: Andrew Hosford, Bricklin Welch, Mohammad Athar
  • Publication number: 20200394067
    Abstract: Aspects of the disclosure relate to a machine-learning transaction-prediction engine for seasoning an anticipated manual transaction. The transaction may occur in a transaction session. The seasoning may occur prior to execution of the anticipated manual transaction, The transaction-prediction engine may include a receiving/storage module configured to receive and store identification information of the transactor. The engine may also include a step-retrieval module configured to retrieve a set of in-session transaction steps associated with the transactor. In addition, the engine may include a history-retrieval module configured to retrieve, based on the stored identification information, historical transactional information associated with the transactor. The historical transaction information comprising a plurality of historical transaction patterns associated with the transactor.
    Type: Application
    Filed: June 17, 2019
    Publication date: December 17, 2020
    Inventors: Andrew Hosford, Bricklin Welch, Mohammad Athar
  • Publication number: 20170290849
    Abstract: A mechanism whereby aberrant Shh signaling converges on the Akt1-mTOR pathway, conferring selective growth advantage and enhanced survival of tumor cells has been identified. Utilizing a mouse model of BCNS, a pivotal role has been discovered for Akt1 signaling in BCC tumorigenesis. Based on the results described here certain embodiments are directed to methods and pharmaceutical formulations for treating BCC/BCNS, other cancers that are Shh+ and Akt+, cancers that are Shh+ and mTOR plus and cancers that are Shh+ by administering therapeutically effective amounts of various combinations of Akt inhibitors, Shh pathway inhibitors such as SMO inhibitors, and mTOR inhibitors.
    Type: Application
    Filed: September 8, 2015
    Publication date: October 12, 2017
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Arianna L. Kim, David Bickers, Mohammad Athar